Abstract:Bright light therapy (BLT) may treat depression symptoms, 1 but how light exerts mood-boosting effects is still under investigation. Here, we evaluate sleep regularity in the association between bright light and depression symptoms. This cross-sectional study of 2011-2014 National Health and Nutrition Examination Survey (NHANES) data, representative of the noninstitutionalized US population, included nonpregnant participants 18 years or older with valid light and actigraphy (wrist-worn GT3X+; ActiGraph) for bright light (time above lux threshold [TALT 1000 ]) and sleep regularity index (SRI) 2 measures (eMethods in Supplement 1) and follows STROBE guidelines. Depression symptoms were measured with the Patient Health Questionnaire-9 (PHQ-9; scores range from 0 to 30, with higher scores indicating greater frequency of depression symptoms). This analysis used publicly available, deidentified data from NHANES, which was approved by the Ethics Review Board of the Centers for Disease Control and Prevention. All participants provided written informed consent. This analysis was conducted between March 2023 and May 2024. Associations between TALT 1000 , SRI, and PHQ-9 score were tested in weighted linear, quasi-Poisson, and logistic regression models adjusted for age, sex, race and ethnicity, season, employment, physical activity, sleep duration, body mass index (BMI), and serum cotinine (eMethods in Supplement 1). Sex differences were tested with weighted t tests. In exploratory analyses, associations between TALT 1000 and vitamin D, vitamin D and SRI, and TALT 1000 and SRI with vitamin D as a potential mediator were tested in weighted linear regression models. P < .05 was considered statistically significant. Analyses were performed in R, version 4.1.1 (R Foundation). There were 6639 participants included in the analysis (mean [SD] age, 49.41 [17.41] years; 52.2% female; self-reported 8.3% Mexican American, 4.4% non-Hispanic Asian, 11.3% non-Hispanic Black, 67.7% non-Hispanic White, 5.7% other Hispanic, and 2.6% other or multiracial). Male participants had greater TALT 1000 and fewer depression symptoms than female participants (Table 1). Greater TALT 1000 was associated with lower depression symptoms (β = −0.19; 95% CI, −0.34 to −0.04) but not more severe depression. TALT 1000 was no longer associated with depression score after adjusting for SRI (β = −0.11; 95% CI, −0.26 to 0.04; P = .13). Longer duration in bright light was associated with more regular sleep (β = 1.60; 95% CI, 0.95-2.25). Likewise, more regular sleep was associated with a lower depression score (β = −0.05; 95% CI, −0.06 to −0.03) and lower odds of mild or more severe depression (OR = 0.98; 95% CI, 0.97-0.99) (Table 2). In exploratory analyses, more vitamin D was associated with greater TALT 1000 and more regular sleep but not depression symptoms. In this study, greater sleep regularity partly explained the association between greater bright light exposure and lower depression symptoms. More vitamin D was associated with more regular sleep timing but not depression. Our findings align with prior population-based research, supporting reduced depression among those with greater daytime light exposure. 3 Bright light therapy can be effective at improving numerous mood outcomes, 4 possibly through effects on sleep and the circadian system. 5 Sleep regularity may be an important modifier of BLT 2 and relate to chronotype and phase angle of entrainment. 6 However, sleep regularity is not often considered in BLT. The phase-shifting effect of light may be limited in people with irregular sleep schedules, requiring a larger dose or altered timing of light exposure. Irregular sleepers may benefit from a light intervention. 2 This study has strengths and limitations. It used a nationally representative sample of adult participants with objective measures of individual light exposure, actigraphy, and vitamin D. This is a cross-sectional analysis, so causality cannot be ascertained, and associations may be bidirectional. Although we are unable to rule out that mood may also influence time spent outdoors and/or bright light avoidance, our results support the need for further prospective analyses to test the causality of these factors. Future studies of BLT should consider the role of sleep regularity. Accepted for Publication: May 19, 2024. Published: July 17, 2024. doi:10.1001/jamanetworkopen.2024.22810 Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2024 Wallace DA et al. JAMA Network Open . Corresponding Author: Danielle A. Wallace, MPH, PhD, Brigham and Women's Hospital, Department of Medicine, 221 Longwood -Abstract Truncated-

Increased Functional Connectivity Between the Midbrain and Frontal Cortex Following Bright Light Therapy in Subthreshold Depression: A Randomized Clinical Trial.

Subclinical alterations of resting state functional brain network for adjunctive bright light therapy in nonseasonal major depressive disorder: A double blind randomized controlled trial

Frequency-Specific Changes in the Fractional Amplitude of the Low-Frequency Fluctuations in the Default Mode Network in Medication-Free Patients with Bipolar II Depression: A Longitudinal Functional MRI Study

The effect of bright light therapy on major depressive disorder: A systematic review and meta-analysis of randomised controlled trials

Neural predictors of treatment response to brain stimulation and psychological therapy in depression: a double-blind randomized controlled trial

High circadian stimulus lighting therapy for depression: Meta-analysis of clinical trials.

Sub-hubs of Baseline Functional Brain Networks Are Related to Early Improvement Following Two-Week Pharmacological Therapy for Major Depressive Disorder.

Bilateral theta-burst stimulation on emotional processing in major depressive disorder: A functional neuroimaging study from a randomized, double-blind, sham-controlled trial

Functional Connectivity Abnormalities of the Subgenual Anterior Cingulate Cortex: Implications for Transcranial Magnetic Stimulation in Depression

Objective and subjective sleep in patients with non-seasonal major depressive disorder and eveningness – Results from a randomized controlled trial of bright light therapy

Bed Nucleus of the Stria Terminalis-Nucleus Accumbens Deep Brain Stimulation for Depression: A Randomized Controlled Trial and an Intracranial Physiological Biomarker Predictor

Cognitive Enhancement in Bipolar Disorder: A Double-Blind, Randomized Controlled Trial Utilizing a Novel DTI-Guided Multimodal Neuro-stimulation Protocol

Bright Light Exposure, Depression Symptoms, and Sleep Regularity

Increased anti-correlation between the left dorsolateral prefrontal cortex and the default mode network following Stanford Neuromodulation Therapy (SNT): analysis of a double-blinded, randomized, sham-controlled trial

A Preliminary Randomized Controlled Trial of Different Treatment Regimens for Melancholic Depression

Structural-functional connectomics in major depressive disorder following aiTBS treatment

Increased Prefrontal Activation During Verbal Fluency Task After Repetitive Transcranial Magnetic Stimulation Treatment in Depression: A Functional Near-Infrared Spectroscopy Study

Burst firing in Output‐Defined Parallel Habenula Circuit Underlies the Antidepressant Effects of Bright Light Treatment

Network effects of Stanford Neuromodulation Therapy (SNT) in treatment-resistant major depressive disorder: a randomized, controlled trial

Striatal Functional Connectivity Alterations after Two-Week Antidepressant Treatment Associated to Enduring Clinical Improvement in Major Depressive Disorder

Efficacy of transcranial direct current stimulation for treating anhedonia in patients with depression: A randomized, double-blind, sham-controlled clinical trial